Johnson & Johnson received approval for a subcutaneous induction regimen of Tremfya to treat ulcerative colitis from the Food and Drug Administration. The pharmaceutical giant said Friday it now ...
Discover how circuit protection and sensing solutions help ensure continuous, reliable operation of low-power wearable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback